O'Reilly S - Search Results

1

A phase I and pharmacologic study of DMP 840 administered by 24-hour infusion.

O'Reilly S, Baker SD, Sartorius S, Rowinsky EK, Finizio M, Lubiniecki GM, Grochow LB, Gray JE, Pieniaszek HJ Jr, Donehower RC. O'Reilly S, et al. Ann Oncol. 1998 Jan;9(1):101-4. doi: 10.1023/a:1008260515869. Ann Oncol. 1998. PMID: 9541690 Free article. Clinical Trial.

2

Phase I and pharmacologic study of topotecan in patients with impaired renal function.

O'Reilly S, Rowinsky EK, Slichenmyer W, Donehower RC, Forastiere AA, Ettinger DS, Chen TL, Sartorius S, Grochow LB. O'Reilly S, et al. J Clin Oncol. 1996 Dec;14(12):3062-73. doi: 10.1200/JCO.1996.14.12.3062. J Clin Oncol. 1996. PMID: 8955651 Clinical Trial.

3

Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group study.

O'Reilly S, Fleming GF, Barker SD, Walczak JR, Bookman MA, McGuire WP 3rd, Schilder RJ, Alvarez RD, Armstrong DK, Horowitz IR, Ozols RF, Rowinsky EK. O'Reilly S, et al. J Clin Oncol. 1997 Jan;15(1):177-86. doi: 10.1200/JCO.1997.15.1.177. J Clin Oncol. 1997. PMID: 8996140 Clinical Trial.

4

Phase I and pharmacologic study of penclomedine, a novel alkylating agent, in patients with solid tumors.

O'Reilly S, Grochow LB, Donehower RC, Chen TL, Bowling K, Hartman NR, Struck RF, Rowinsky EK. O'Reilly S, et al. J Clin Oncol. 1997 May;15(5):1974-84. doi: 10.1200/JCO.1997.15.5.1974. J Clin Oncol. 1997. PMID: 9164209 Clinical Trial.

5

High-dose topotecan with granulocyte-colony stimulating factor in fluoropyrimidine-refractory colorectal cancer: a phase II and pharmacodynamic study.

Rowinsky EK, Baker SD, Burks K, O'Reilly S, Donehower RC, Grochow LB. Rowinsky EK, et al. Ann Oncol. 1998 Feb;9(2):173-80. doi: 10.1023/a:1008266630701. Ann Oncol. 1998. PMID: 9553662 Clinical Trial.

6

Phase I and pharmacologic study of oral fluorouracil on a chronic daily schedule in combination with the dihydropyrimidine dehydrogenase inactivator eniluracil.

Baker SD, Diasio RB, O'Reilly S, Lucas VS, Khor SP, Sartorius SE, Donehower RC, Grochow LB, Spector T, Hohneker JA, Rowinsky EK. Baker SD, et al. J Clin Oncol. 2000 Feb;18(4):915-26. doi: 10.1200/JCO.2000.18.4.915. J Clin Oncol. 2000. PMID: 10673535 Clinical Trial.

7

Phase I and pharmacologic studies of topotecan in patients with impaired hepatic function.

O'Reilly S, Rowinsky E, Slichenmyer W, Donehower RC, Forastiere A, Ettinger D, Chen TL, Sartorius S, Bowling K, Smith J, Brubaker A, Lubejko B, Ignacio V, Grochow LB. O'Reilly S, et al. J Natl Cancer Inst. 1996 Jun 19;88(12):817-24. doi: 10.1093/jnci/88.12.817. J Natl Cancer Inst. 1996. PMID: 8637048 Clinical Trial.

8

A phase II trial of topotecan in patients with previously untreated pancreatic cancer.

O'Reilly S, Donehower RC, Rowinsky EK, Ord S, Grochow LB. O'Reilly S, et al. Anticancer Drugs. 1996 Jun;7(4):410-4. doi: 10.1097/00001813-199606000-00006. Anticancer Drugs. 1996. PMID: 8826609 Clinical Trial.

9

Experimental chemotherapeutic agents for the treatment of colorectal carcinoma.

O'Reilly S, Rowinsky EK. O'Reilly S, et al. Hematol Oncol Clin North Am. 1997 Aug;11(4):721-58. doi: 10.1016/s0889-8588(05)70458-5. Hematol Oncol Clin North Am. 1997. PMID: 9257153 Free article. Review.

10

A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer.

Dees EC, O'Reilly S, Goodman SN, Sartorius S, Levine MA, Jones RJ, Grochow LB, Donehower RC, Fetting JH. Dees EC, et al. Cancer Invest. 2000;18(6):521-9. doi: 10.3109/07357900009012191. Cancer Invest. 2000. PMID: 10923100

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

772 results

Search Page

Filters